Key result
Treated hyperlipidemic women display more favorable standard lipids but higher Lp(a) and pro-BNP versus men.
Why the study?
Does female sex influence metabolic and clinical characteristics in patients treated for hyperlipidemia?
Cross-Sectional (n=99)
Does female sex influence metabolic and clinical characteristics in patients treated for hyperlipidemia?
Sex-specific differences exist in lipid profiles and biomarkers among treated hyperlipidemic patients, suggesting a need for personalized cardiovascular risk assessment, particularly around menopause.
Sex differences in lipids and biomarkers among treated hyperlipidemic patients should not change practice; hypothesis-generating for sex-specific cardiovascular risk assessment.
Objective . The aim of this study was to evaluate sex specific differences of metabolic and clinical characteristics of treated hyperlipidemic men and women (HL-men and HL-women). Methods . In this study vascular and metabolic characteristics of 35 HL-women and 64 HL-men were assessed. In addition a sex specific analysis of metabolic and nutritional habits of HL-patients with prediabetes (HL-IGR) was done. Results . HL-women were older and had favourable concentrations of high density lipoprotein cholesterol (HDL-cholesterol), triglycerides (TG), and triglyceride/HDL-cholesterol ratio (TG/HDL-ratio) but were also shown to have higher concentrations of lipoprotein-a compared to HL-men. HL-men were characterized as having higher levels of liver-specific parameters and body weight as well as being more physically active compared to HL-women. Brain natriuretic peptide (pro-BNP) was higher in HL-women than HL-men, while no differences in metabolic syndrome and glycemic parameters were shown. HL-IGR-women were also older and still had a better profile of sex specific lipid parameters, as well as a lower body weight compared to HL-IGR-men. No differences were seen in vascular parameters such as the intima media thickness (IMT). Conclusion . HL-women were older and had overall more favourable concentrations of lipid parameters and liver enzymes but did not differ regarding vascular morphology and insulin sensitivity compared to HL-men of comparable body mass index (BMI).
No takes yet. Share an insight, caveat, or question.
Leutner et al. (2016) conducted a cross-sectional in Hyperlipidemia (n=99). Female sex vs. Male sex was evaluated on Sex-specific differences in metabolic and clinical characteristics (lipid parameters, liver enzymes, and IMT). Treated hyperlipidemic women had more favorable HDL and triglycerides but higher lipoprotein-a and pro-BNP compared to men, with no difference in vascular morphology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: